Skip to content

Clinical trials

Completed Lupus Erythematosus, Systemic trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Status: Completed Country / region: Brazil Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20071
20083
20104
20116
20124
20134
20141
20174
20181
20191
20201
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma5
Human Genome Sciences Inc., a GSK Company4
MedImmune LLC4
Anthera Pharmaceuticals3
Bristol-Myers Squibb3
GlaxoSmithKline2
University of Sao Paulo General Hospital2
AstraZeneca1
Celgene1
Children's Hospital Medical Center, Cincinnati1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic35
Autoimmune Diseases10
Acquired Immunodeficiency Syndrome1
Arthritis1
Arthritis, Rheumatoid1
COVID-191
Connective Tissue Diseases1
Fatigue1
Glomerulonephritis1
HIV Infections1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.